4
Changes in Ownership
Keros Therapeutics, Inc. Filed Acc 0002081460-26-000004
Options or other derivatives
- Chief Legal Officer acquired 80,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Cho Esther · Chief Legal Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-02-24 | Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) | +80,000 | 80,000 | D |
Loading xslF345X05/form4-02262026_040212.xml…